Cancer-seeking molecular delivery system could boost immunotherapy drug, research finds

For past decades, the treatment of cancer has generally meant surgery, radiation, chemotherapy, or a combination of the above. Through recent work from a collaboration of researchers from the University of Rhode Island and Yale University comes the promising new approach of delivering immunotherapy agents, STING agonists, via a cancer-seeking molecular delivery system. The delivery relies on the acid-seeking molecule- pHLIP. These molecules deliver cargo directly to the tumor environment via targeting of the high acidity of cancerous tumors. Through this novel drug delivery technique, cancer immunotherapy may become even more effective.

Continue reading